Thomas C. Fardon

3.3k total citations · 2 hit papers
37 papers, 2.1k citations indexed

About

Thomas C. Fardon is a scholar working on Pulmonary and Respiratory Medicine, Emergency Medical Services and Epidemiology. According to data from OpenAlex, Thomas C. Fardon has authored 37 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 7 papers in Emergency Medical Services and 6 papers in Epidemiology. Recurrent topics in Thomas C. Fardon's work include Cystic Fibrosis Research Advances (24 papers), Neonatal Respiratory Health Research (20 papers) and Respiratory and Cough-Related Research (8 papers). Thomas C. Fardon is often cited by papers focused on Cystic Fibrosis Research Advances (24 papers), Neonatal Respiratory Health Research (20 papers) and Respiratory and Cough-Related Research (8 papers). Thomas C. Fardon collaborates with scholars based in United Kingdom, Italy and Ireland. Thomas C. Fardon's co-authors include James D. Chalmers, Stefano Aliberti, Pieter Goeminne, Melissa J. McDonnell, Anthony De Soyza, Lieven Dupont, Sara Lonni, Adam T. Hill, Simon Finch and J. K. Davidson and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Thomas C. Fardon

35 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Bronchiectasis Severity Index. An International Derivation and Validation Study

2014 665 citations James D. Chalmers, Pieter Goeminne et al. American Journal of Respiratory and Critical Care Medicine profile →
Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis

2017 247 citations James D. Chalmers, Kelly Moffitt et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers

Countries citing papers authored by Thomas C. Fardon

Since Specialization

Citations

This map shows the geographic impact of Thomas C. Fardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas C. Fardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas C. Fardon more than expected).

Fields of papers citing papers by Thomas C. Fardon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas C. Fardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas C. Fardon. The network helps show where Thomas C. Fardon may publish in the future.

Co-authorship network of co-authors of Thomas C. Fardon

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas C. Fardon. A scholar is included among the top collaborators of Thomas C. Fardon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas C. Fardon. Thomas C. Fardon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 2021 ·Annals of the American Thoracic Society ·Stefano Aliberti, Giovanni Sotgiu, Andrea Gramegna, Melissa J. McDonnell, Eva Polverino, Antoní Torres, Pieter Goeminne, Katerina Dimakou, Michal Shteinberg, Oriol Sibila, (unknown), Thomas C. Fardon, Robert Rutherford, Simone Dore, Laura Saderi, Paola Faverio, Francesco Amati, Angelo Guido Corsico, Francesco Blasi, James D. Chalmers	8
2	Relationship between Symptoms, Exacerbations, and Treatment Response in Bronchiectasis 2020 ·American Journal of Respiratory and Critical Care Medicine ·Yong‐hua Gao, (unknown), Simon Finch, Mike Lonergan, Stefano Aliberti, Anthony De Soyza, Thomas C. Fardon, Gregory Tino, James D. Chalmers	31
3	Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST) 2020 ·Respiratory Research ·(unknown), Megan Crichton, Simon Finch, (unknown), Pieter Goeminne, Stefano Aliberti, Thomas C. Fardon, James D. Chalmers	13
4	Pregnancy Zone Protein Is Associated with Airway Infection, Neutrophil Extracellular Trap Formation, and Disease Severity in Bronchiectasis 2019 ·American Journal of Respiratory and Critical Care Medicine ·Simon Finch, Amelia Shoemark, Alison Dicker, Holly R. Keir, Alexandria Smith, Samantha Ong, Brandon Tan, (unknown), Thomas C. Fardon, Diane Cassidy, Jeffrey Huang, James D. Chalmers	53
5	Validation of the COPD Assessment Test (CAT) as an Outcome Measure in Bronchiectasis 2019 ·CHEST Journal ·Simon Finch, (unknown), (unknown), Thomas C. Fardon, James D. Chalmers	27
6	The independent contribution ofPseudomonas aeruginosainfection to long-term clinical outcomes in bronchiectasis 2018 ·European Respiratory Journal ·David Araújo, Michal Shteinberg, Stefano Aliberti, Pieter Goeminne, Adam T. Hill, Thomas C. Fardon, Dušanka Obradović, (unknown), M Trautmann, Angela Davis, Katerina Dimakou, Eva Polverino, Anthony De Soyza, Melissa J. McDonnell, James D. Chalmers	150
7	Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis breakdown → 2017 ·American Journal of Respiratory and Critical Care Medicine ·James D. Chalmers, Kelly Moffitt, Guillermo Suárez-Cuartín, Oriol Sibila, Simon Finch, Elizabeth Furrie, Alison Dicker, Karolina Wrobel, J.S. Elborn, Brian K. Walker, Lorraine Martin, Sara E. Marshall, Jeffrey Huang, Thomas C. Fardon	247
8	Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis 2017 ·CHEST Journal ·Anthony De Soyza, Melissa J. McDonnell, Pieter Goeminne, Stefano Aliberti, Sara Lonni, John M. Davison, Lieven Dupont, Thomas C. Fardon, Robert Rutherford, Adam T. Hill, James D. Chalmers	60
9	The heterogeneity of systemic inflammation in bronchiectasis 2017 ·Respiratory Medicine ·Aarash Saleh, James D. Chalmers, Anthony De Soyza, Thomas C. Fardon, (unknown), Jonathan Scott, A. John Simpson, Jeremy Brown, John R. Hurst	51
10	The generalizability of bronchiectasis randomized controlled trials: A multicentre cohort study 2016 ·Respiratory Medicine ·James D. Chalmers, Melissa J. McDonnell, Robert Rutherford, J. K. Davidson, Simon Finch, Megan Crichton, Lieven Dupont, Adam T. Hill, Thomas C. Fardon, Anthony De Soyza, Stefano Aliberti, Pieter Goeminne	16
11	Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts 2016 ·Thorax ·Melissa J. McDonnell, Stefano Aliberti, Pieter Goeminne, Katerina Dimakou, (unknown), J. K. Davidson, Chris Ward, John G. Laffey, Simon Finch, Alberto Pesci, Lieven Dupont, Thomas C. Fardon, Dušan Škrbić, Dušanka Obradović, Steven Cowman, Michael R. Loebinger, Robert Rutherford, Anthony De Soyza, James D. Chalmers	99
12	Clinical phenotypes in adult patients with bronchiectasis 2016 ·European Respiratory Journal ·Stefano Aliberti, Sara Lonni, Simone Dore, Melissa J. McDonnell, Pieter Goeminne, Katerina Dimakou, Thomas C. Fardon, Robert Rutherford, Alberto Pesci, Marcos I. Restrepo, Giovanni Sotgiu, James D. Chalmers	174
13	The Bronchiectasis Severity Index. An International Derivation and Validation Study breakdown → 2014 ·American Journal of Respiratory and Critical Care Medicine ·James D. Chalmers, Pieter Goeminne, Stefano Aliberti, Melissa J. McDonnell, Sara Lonni, J. K. Davidson, Lucy Poppelwell, Waleed Salih, Alberto Pesci, Lieven Dupont, Thomas C. Fardon, Anthony De Soyza, Adam T. Hill	665
14	Invasive pulmonary aspergillosis post extracorporeal membrane oxygenation support and literature review 2014 ·Medical Mycology Case Reports ·Benjamin J. Parcell, (unknown), Elizabeth M. Johnson, Thomas C. Fardon, (unknown)	5
15	Patterns of spirometry in bronchiectasis patients and relationship to markers of disease severity and hospitalisation 2013 ·European Respiratory Journal ·(unknown), Lucy Poppelwell, Waleed Salih, James D. Chalmers, Thomas C. Fardon	2
16	A Randomized Primary Care Trial of Steroid Titration Against Mannitol in Persistent Asthma 2011 ·CHEST Journal ·Brian J. Lipworth, Philip Short, Peter A. Williamson, Karine Clearie, Thomas C. Fardon, Cathy Jackson	47
17	Paradoxical Trough Effects of Triple Therapy With Budesonide/Formoterol and Tiotropium Bromide on Pulmonary Function Outcomes in COPD 2010 ·CHEST Journal ·Peter A. Williamson, Philip Short, Karine Clearie, Sriram Vaidyanathan, Thomas C. Fardon, (unknown), Brian J. Lipworth	14
18	Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic 2010 ·Journal of Antimicrobial Chemotherapy ·James D. Chalmers, Mudher Al-Khairalla, PM Short, Thomas C. Fardon, J H Winter	44
19	Airway and Systemic Effects of Hydrofluoroalkane Formulations of High-Dose Ciclesonide and Fluticasone in Moderate Persistent Asthma 2005 ·CHEST Journal ·Daniel K.C. Lee, Thomas C. Fardon, (unknown), Kay Haggart, Lesley C. McFarlane, Brian J. Lipworth	57
20	Effects of single or combined histamine H₁‐receptor and leukotriene CysLT₁‐receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis 2004 ·British Journal of Clinical Pharmacology ·Daniel K.C. Lee, Catherine Jackson, (unknown), Thomas C. Fardon, Brian J. Lipworth	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact